Takeda says farewell to CFO, suite of clinical-stage programs in Q3 update

Take­da’s CFO is out, the com­pa­ny an­nounced Thurs­day along­side a se­ries of pipeline cuts.

Cos­ta Saroukos will step down on April 1 to move clos­er to his fam­i­ly in Aus­tralia, he said. He spent six years in the job and helped close one of the biggest deals in phar­ma his­to­ry — the $62 bil­lion Shire ac­qui­si­tion in 2019.

“Since then, he has been in­stru­men­tal in Take­da’s trans­for­ma­tion in­to a glob­al bio­phar­ma­ceu­ti­cal com­pa­ny and is hand­ing over an ex­cep­tion­al fi­nance or­ga­ni­za­tion,” CEO Christophe We­ber said on a call with in­vestors on Thurs­day as the com­pa­ny an­nounced its fis­cal third-quar­ter re­sults.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.